Institut Catala d'Oncologia Badalona, Hospital Germans Trias i Pujol
Badalona, Barcelona 08916
1 studies enrolling now · 3 studies all time
What they study most
ALK-positive Advanced NSCLC, Diffuse Large B-cell Lymphoma (DLBCL), Squamous Cell Carcinoma of the Head and Neck
Studies at this site
- A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Recruiting now
- A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
- Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early